Start with how you take the tablet
Ask yourself whether you manage the fasting period, the right amount of water and the wait before food or other medicines every day. Oral semaglutide is absorbed unevenly, and the label points to how the tablet is taken whenever the response is lower than expected. The question is practical. Nobody is blaming you.
Record the strength you take, how long you have been on it, any missed days and any breaks in treatment. Your start date alone does not show the prescriber how much continuous treatment you have had. Review symptoms before you decide whether a planned dose increase suits you.
Monitoring depends on your health and medicines
If you take insulin or a sulfonylurea, you need a plan for hypoglycaemia. If you take levothyroxine, your thyroid levels may need checking. If you take warfarin or a similar anticoagulant, you may need closer INR checks when semaglutide starts. The label names each of these.
Diabetic eye disease, significant kidney problems and lasting stomach or bowel symptoms change what follow-up you need. A healthy weight trend does not cancel these concerns. No single blood-test panel applies to every tablet user, so you do not need to buy tests your history does not call for.
Keep a short record
A short record is easier to keep up than a detailed spreadsheet. Note your dose, your weight at agreed intervals, important symptoms and any change to other medicines. Add whether symptoms get in the way of meals, drinking, sleep or normal activities. This shows whether a side effect is a nuisance or a reason to change treatment.
Measurements should help your care. They should not turn into a daily verdict on you. Agree how often to weigh yourself and which other outcomes count. If weighing causes distress or disordered eating, say so openly. Your team should change the monitoring and arrange the right support.
Every review should end in a decision
Each review should decide whether to continue, increase, pause, investigate symptoms or look at another treatment. The review should also set the date of the next one and name who deals with urgent problems. Renewing a prescription without looking at new information is an incomplete follow-up plan.
Tell your GP about private treatment and any significant change. If you move provider, ask for an accurate treatment history, including reactions and breaks in treatment. The next clinician needs the full picture of benefit and risk, beyond your latest tablet strength.
Good follow-up also checks you understand the plan. You should know your current strength, how to take the tablet and which symptoms need help. If the instructions confuse you, ask for them in plain language or an accessible format. A plan works only when you can understand and follow each step.
Questions to take to your appointment
Ask which outcomes will show the treatment is worth continuing, which checks your other medicines call for and how the team will tackle problems with taking the tablet. Agree a clear way to report symptoms between reviews.
A review also shows where the medicine clashes with daily life. If the fasting rule keeps conflicting with work or other daily tablets, explain the conflict honestly. Recording missed doses again and again helps less than agreeing a routine or a treatment you can follow.
Sources
Your own medicine leaflet and prescriber come first. A source from another country does not mean the same rule applies in the UK.
- Wegovy pill UK Summary of Product Characteristics medicines.org.uk
- Wegovy pill UK patient information leaflet medicines.org.uk
- MHRA UK authorisation announcement gov.uk
Spotted something out of date? Report a mistake.